Eli Lilly and Co at Evercore ISI HealthCONx Conference Transcript
(technical difficulty)
for being here. Pleasure to have management team from Eli Lilly. There's a ton to go through. But Dan, I'll turn it over to you on what's on top of your mind, and we'll jump right into it.
Yes. No. Thanks for hosting us here. It's been a great meeting so far, and nice to have this opportunity to talk at a fireside. I guess probably most people are excited about Lilly because of what we're doing in obesity and Alzheimer's disease. But just a reminder that we have a great business in immunology with a couple of new products being planned to launch.
We're also doing great things in oncology with Verzenio as a huge product and Jaypirca, which is in the early stages of launching across indications. So really a very diversified pharmaceutical company even though I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |